Second long term HRT trial stopped early

A second trial looking into the long term effects of hormone replacement therapy (HRT) has been stopped early.

The UK Medical Research Council (MRC) announced last week that a decision had been taken to halt the women's international study of long duration oestrogen after menopause (WISDOM) for “scientific and practical reasons.” The trial, which has cost £10m ($15.5m; €15.9m), was due to be completed in 2016.

WISDOM was investigating the long term effects of oestrogen combined with progestogen and of oestrogen alone on the …